ReachMD

Be part of the knowledge.™

Oncology and Hematology

1785

LikeLikedUnlike

Episodes 1-15 of 437

- Matt Birnholz, MD
  Peer
0
Advances in Women's Health
What’s New in Breast Cancer Care? An Overview of ESMO 2019
- Matt Birnholz, MD
  Peer
- I-Mei Siu
  Peer
0
Advances in Women's Health
A Chat with “Cancer Discovery” at ESMO
- Matt Birnholz, MD
  Peer
- Giuseppe Curigliano, MD, PhD
  Peer
0
Advances in Women's Health
New Findings on Triple-Negative Breast Cancer Treatments
- Matt Birnholz, MD
  Peer
- Hans Petter Eikesdal, MD
  Peer
0
Advances in Women's Health
Are PARP Inhibitors the Future of Treating Triple-Negative Breast Cancer?
- Matt Birnholz, MD
  Peer
- Susanne Ahlstedt Karlsson, PhD
  Peer
0
Advances in Women's Health
Experiences of Endocrine Treatment After Breast Cancer Surgery
- Matt Birnholz, MD
  Peer
- Randi J. Reidunsdatter, MD
  Peer
0
Advances in Women's Health
Do Breast Cancer Patients & Oncologists Agree on the Severity of Symptoms Aft...
- Joshua Richter, MD
  Peer
1
$Overall Survival Data in Patients with Relapsed/Refractory Multiple Myeloma$ $Overall Survival Data in Patients with Relapsed/Refractory Multiple Myeloma$
Medical Industry Feature
Overall Survival Data in Patients with Relapsed/Refractory Multiple Myeloma
- Jeffrey V. Matous, MD
  Peer
1
$Treating Relapsed/Refractory Multiple Myeloma with a Triplet Therapy$ $Treating Relapsed/Refractory Multiple Myeloma with a Triplet Therapy$
Medical Industry Feature
Treating Relapsed/Refractory Multiple Myeloma with a Triplet Therapy
- Jennifer Caudle, DO
  Peer
- Sunil Singhal, MD, FACS
  Peer
0
Medical Breakthroughs from Penn Medicine
Illuminating Innovations in Tumor Resection Surgery
- Karen L. Reckamp, MS, MD
  Peer
- Mark A. Socinski, MD
  Peer
- Helena Yu, MD
  Peer
1
CME/CE
Advanced/Metastatic NSCLC Treatment: Advancements for Patients Without Target...
- William Mencia, MD
  Peer
- Biree Andemariam, MD
  Peer
- Colin Kaide, MD
  Peer
1
CME/CE
Rare Blood Disorders & Hemoglobinopathies: Updates on Diagnosis & Treatment i...
- Charles Geyer, MD
  Peer
3
CME/CE
Improving Outcomes in HER2+ Early Breast Cancer
- John J. Russell, MD
  Peer
- Mark Sundermeyer, MD
  Peer
1
Closing the Gaps in NSCLC
The Role of Primary Care in Diagnosing NSCLC
- Robert Mocharnuk, MD
  Peer
- Ingrid A. Mayer, MD
  Peer
2
CME/CE
HR+/HER2-Negative Breast Cancer: Revolutions in Precision Medicine with PI3K ...
- Omid Hamid, MD
  Peer
- Do-Youn Oh, MD, PhD
  Peer
10
CME/CE
Biliary Tract Carcinoma: Are We at the Point of Change?

Loading...

Programs 10/20/19

Playlist:

Recommended